ORION CORPORATION PRESS RELEASE 8 JANUARY 2026 at 12.00 EET Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in ...

Aktis Oncology is seeking a valuation of as much as $840 million in its U.S. initial public offering, the biotechnology ...

Aktis Oncology Inc., a clinical-stage biotechnology company focused on using so-called radiopharmaceuticals for treatments, ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Today, MPM Capital (“MPM”), one of the world’s leading biotech investment firms, announced that it has raised $850 million for its second Oncology Impact Fund (“OIF ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--MPM Capital (MPM), one of the world’s prominent biotech investment firms, has announced the addition of Detlev Biniszkiewicz, Ph.D. to its venture investment team as ...

MPM Capital and Dana-Farber Cancer Institute have formed a venture philanthropy alliance, raising a $100 million investment fund and $26 million in donations to support early stage research.

CAMBRIDGE, Mass. – Semma Therapeutics, a company developing a cell therapy for Type 1 diabetes, announced today that it has closed a $44 million Series A consisting of equity financing and strategic ...

Partners Group has agreed to buy UK pet-food business MPM Products from its UK private-equity peer 3i. Established 2002, Manchester-based MPM’s portfolio includes cat-focused brands such as Applaws, ...